Trial shows that risk of a major adverse cardiovascular event is eight per cent lower in people on new therapy ...

Medicines for diabetes show that Mounjaro outperforms Trulicity in reducing serious heart risks in diabetes patients according to Eli Lilly study ...

The trial included over 13,000 people across 30 countries and ran for more than 4.5 years, making it the largest and longest study on tirzepatide so far, the company said ...

As discussed in this LipoVive review, the formula is a natural weight loss aid made with clinically approved herbs and plant compounds. The main target of the formula is to support quick and ...

The trial enrolled more than 13,000 participants across 30 countries and lasted more than four and a half years. It was also the largest and longest study of tirzepatide --- the active ingredient in ...

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

A rally in stocks sputtered ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, ...